Skip to main content
Top

Cancer Causes & Control

Issue 8/2018

Content (9 Articles)

Original paper

Height, waist circumference, body mass index, and body somatotype across the life course and risk of glioma

David J. Cote, Mary K. Downer, Timothy R. Smith, Stephanie A. Smith-Warner, Kathleen M. Egan, Meir J. Stampfer

Original paper

Breast cancer awareness in the sub-Saharan African ABC-DO cohort: African Breast Cancer—Disparities in Outcomes study

Fiona McKenzie, Annelle Zietsman, Moses Galukande, Angelica Anele, Charles Adisa, Groesbeck Parham, Leeya Pinder, Isabel dos Santos Silva, Valerie McCormack

Original paper

Mapping hot spots of breast cancer mortality in the United States: place matters for Blacks and Hispanics

Justin Xavier Moore, Kendra J. Royston, Marvin E. Langston, Russell Griffin, Bertha Hidalgo, Henry E. Wang, Graham Colditz, Tomi Akinyemiju

Original paper

Interactions of alcohol and postmenopausal hormone use in regards to mammographic breast density

Lusine Yaghjyan, Graham Colditz, Heather Eliassen, Bernard Rosner, Aleksandra Gasparova, Rulla M. Tamimi

Original paper

Racial differences in maternal and umbilical cord blood leukocyte telomere length and their correlations

Kari A. Weber, Christopher M. Heaphy, Corinne E. Joshu, Jiayun Lu, Sabine Rohrmann, Jessica L. Bienstock, Tanya Agurs-Collins, Alan K. Meeker, Elizabeth A. Platz

Original paper

Regular aspirin use and gene expression profiles in prostate cancer patients

Konrad H. Stopsack, Ericka M. Ebot, Mary K. Downer, Travis A. Gerke, Jennifer R. Rider, Philip W. Kantoff, Lorelei A. Mucci

Original paper

Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer

Marie C. Bradley, Yingjun Zhou, Andrew N. Freedman, Marianne Ulcickas Yood, Charles P. Quesenbery, Reina Haque, Stephen K. Van Den Eeden, Andrea E. Cassidy-Bushrow, David Aaronson, Arnold L. Potosky

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine